LA JOLLA PHARMACEUTICAL CO Insider Trading for February 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LA JOLLA PHARMACEUTICAL CO.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in LA JOLLA PHARMACEUTICAL CO for February 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 19 2020 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Option Exercise | A | 8.40 | 229 | 1,924 | 229 | |
| Feb 19 2020 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Grant | A | 7.14 | 229 | 1,635 | 8,244 | 8 K to 8.2 K (+2.86 %) |
| Feb 19 2020 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 8.40 | 83 | 697 | 83 | |
| Feb 19 2020 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Grant | A | 7.14 | 83 | 593 | 8,007 | 7.9 K to 8 K (+1.05 %) |
| Feb 19 2020 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 8.40 | 115 | 966 | 115 | |
| Feb 19 2020 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 7.14 | 115 | 821 | 80,535 | 80.4 K to 80.5 K (+0.14 %) |
| Feb 04 2020 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 6.85 | 101 | 692 | 101 | |
| Feb 04 2020 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Grant | A | 5.82 | 101 | 588 | 7,924 | 7.8 K to 7.9 K (+1.29 %) |
| Feb 04 2020 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 6.85 | 141 | 966 | 141 | |
| Feb 04 2020 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 5.82 | 141 | 821 | 80,420 | 80.3 K to 80.4 K (+0.18 %) |
| Feb 04 2020 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Option Exercise | A | 6.85 | 282 | 1,932 | 282 | |
| Feb 04 2020 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Grant | A | 5.82 | 282 | 1,641 | 8,015 | 7.7 K to 8 K (+3.65 %) |
| Feb 03 2020 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 6.80 | 75,003 | 509,833 | 8,080,345 | 8 M to 8.1 M (+0.94 %) |
| Feb 03 2020 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 6.75 | 13,292 | 89,705 | 8,005,342 | 8 M to 8 M (+0.17 %) |
| Feb 03 2020 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 6.72 | 81,475 | 547,431 | 7,992,050 | 7.9 M to 8 M (+1.03 %) |